Identifying all these variants will strengthen our understanding of the effect of GBA1 variants, and it facilitates recruitment for the upcoming GBA1‐targeted trials, hopefully resulting in a first disease‐modifying drug for PD.12 The gene discussed is GBA1; the disease is Parkinson disease.